AstraZeneca PLC (AZN) stock saw a modest uptick, ending the day at $67.01 which represents a slight increase of $0.43 or 0.65% from the prior close of $66.58. The stock opened at $67.19 and touched a ...
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ASTRAZENECA PLC (AZN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE FEBRUARY 21, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING ...
AstraZeneca PLC AZN shares inched down 0.05% to £109.82 Friday, on what proved to be an all-around dismal trading session for ...
A class action securities lawsuit was filed against AstraZeneca PLC that seeks to recover losses of shareholders who were adversely affected by alleged securities fra ...
Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...
SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
UBS has recently raised AstraZeneca PLC (AZN) stock to Neutral rating, as announced on November 20, 2024, according to Finviz. Earlier, on November 6, 2024, Deutsche Bank had raised the stock from a ...
In the latest trading session, Astrazeneca (AZN) closed at $66.58, marking a -0.09% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.16%. Elsewhere, the Dow ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback